Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Meds Apotek

35.80 SEK

0.00 %

Less than 1K followers

MEDS

First North Stockholm

Retailers

Consumer Goods & Services

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
0.00 %
-21.15 %
-28.11 %
-22.84 %
-
-
-
-
-38.28 %

Meds Apotek is a full-scale e-commerce pharmacy operating in the Swedish outpatient market. The company offers its customers an extensive product range consisting of prescription drugs, over-the-counter drugs and a wide selection of merchandise such as beauty products, dietary supplements, children's products, fitness products, food and beverages and home & household products. Meds Apotek was founded in 2017 and is headquartered in Stockholm.

Read more
Market cap
664.88M SEK
Turnover
393.8 SEK
Revenue
1.01B
EBIT %
-0.24 %
P/E
81.36
Dividend yield-%
-
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5/5
2026

Interim report Q1'26

21/5
2026

General meeting '26

21/7
2026

Interim report Q2'26

All
Press releases
ShowingAll content types
Regulatory press release2/10/2026, 6:30 AM

MEDS bokslutskommuniké 2025: Omsättning över miljarden med god tillväxt och lönsamhet

Meds Apotek
Regulatory press release2/10/2026, 6:30 AM

MEDS Year-End Report 2025: Net sales exceeded SEK 1 billion, with solid growth and profitability

Meds Apotek
Press release2/5/2026, 9:20 AM

Invitation to presentation of MEDS 2025 year-end report on February 10, 2026

Meds Apotek

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2/3/2026, 9:00 AM

MEDS mångdubblar logistikcenter för ökad kapacitet

Meds Apotek
Regulatory press release11/7/2025, 6:30 AM

MEDS delårsrapport Q3 2025: Fortsatt stark tillväxt med lönsamhet

Meds Apotek
Regulatory press release11/7/2025, 6:30 AM

MEDS Interim Report Q3 2025: Continued Strong Growth with Profitability

Meds Apotek
Press release10/29/2025, 11:05 AM

Invitation to presentation of MEDS Q3 2025 Interim Report on November 7, 2025

Meds Apotek
Regulatory press release10/23/2025, 7:10 PM

Meddelande om stabiliseringsåtgärder och avslutande av stabiliseringsperioden

Meds Apotek
Regulatory press release10/23/2025, 7:10 PM

Notice of stabilisation measures and termination of stabilisation period

Meds Apotek
Regulatory press release10/17/2025, 5:30 PM

Meddelande om stabiliseringsåtgärder

Meds Apotek
Regulatory press release10/17/2025, 5:30 PM

Stabilisation notice

Meds Apotek
Regulatory press release10/8/2025, 4:00 PM

Meddelande om stabiliseringsåtgärder

Meds Apotek
Regulatory press release10/8/2025, 4:00 PM

Stabilisation notice

Meds Apotek
Regulatory press release9/23/2025, 6:00 AM

MEDS offentliggör utfallet av erbjudandet och handeln på Nasdaq First North Premier Growth Market inleds idag

Meds Apotek
Regulatory press release9/23/2025, 6:00 AM

MEDS announces the outcome of the offering and trading on Nasdaq First North Premier Growth Market commences today

Meds Apotek
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.